Shanghai Fosun Pharmaceutical Industrial Development
Shanghai Fosun Pharmaceutical Industrial Development is a China-based pharmaceutical company running 5 late-stage cancer trials of FCN-159 and Test group (Group A): FCN-159 in non-small-cell lung cancer and rare cancers of childhood.
Overview
Shanghai Fosun Pharmaceutical Industrial Development, based in Shanghai, China, is a pharmaceutical company and part of Shanghai Fosun Pharmaceutical (Group) Co., Ltd. listed as 600196.SH; 02196.HK. Part of the Fosun Pharma group, a China-rooted global pharmaceutical and healthcare group with operations spanning pharmaceuticals, medical devices, diagnostics, healthcare services and pharmaceutical distribution. On ClinicalTrials.gov it is the lead sponsor of 5 recruiting or active phase 2 and phase 3 interventional cancer trials (2 in phase 3), testing FCN-159 and Test group (Group A): FCN-159 in non-small-cell lung cancer and rare cancers of childhood. The largest, NCT06569420 (Study Of Comparing SAF-189s With Crizotinib In First Line ALK-Positive Advanced and Metastatic NSCLC), plans to enrol 275 participants (actual). Sponsor and trial facts are from the ClinicalTrials.gov registry, checked on 2026-09-11; company facts are from the official website.
Similar pages
not linked directly; found by shared links- CompanyShanghai Kechow Pharma
Shares Rare cancers of childhood (NCI PDQ umbrella) and the tag ctgov-sponsor.
- CompanyAvistone Biotechnology
Shares Non-small-cell lung cancer and the tag ctgov-sponsor.
- CompanyMaia Biotechnology
Shares Non-small-cell lung cancer and the tag ctgov-sponsor.
- CompanySTCube
Shares Non-small-cell lung cancer and the tag ctgov-sponsor.
- CompanyCivaTech Oncology
Shares Non-small-cell lung cancer and the tag ctgov-sponsor.
- CompanyKrystal Biotech
Shares Non-small-cell lung cancer and the tag ctgov-sponsor.
- CompanymAbxience Research S.L.
Shares Non-small-cell lung cancer and the tag ctgov-sponsor.
- CompanyCelltrion
Shares Non-small-cell lung cancer and the tag ctgov-sponsor.